|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
Profile of the Month
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
|
{{if listFind(vars.channel_names, "MSIF News")}}
|
|
MSIF News
 |
 |
| Summaries of new MSIF activities, events, projects, programmes, resources, publications and more. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
Profile of the Month
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
Profile of the Month : October 2008
Kathleen Wilson
 Name: Kathleen Wilson Country: USA Age: 50 Occupation: Founding President, MSWorld, Inc Type of MS: Relapsing remitting Year of diagnosis: 1988
My motto is ‘wellness is a state of mind.’ I believe that living well is a choice that we make every day and our personal happiness has everything to do with how we feel about ourselves and how we connect and share with others.
Read the full article here:
English Espanol Italiano Francais Deutsch Русский
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study
The authors investigated the side effects of mitoxantrone, a chemotherapy drug used to treat aggressive MS, in women. They found that whilst it may affect fertility, this risk is reduced if hormones are used during the treatment.
authors: Cocco E, Sardu C, Gallo P, Capra R, Amato MP, Trojano M, Uccelli A, Marrosu MG; the FEMIMS group
source: Mult Scler. 2008 Aug 13. [Epub ahead of print]
read more
Grey matter pathology in multiple sclerosis
In recent years it has been appreciated that MS affects grey as well as white matter in the brain. This article gives an overview of the importance of grey matter involvement in MS and reviews different theories on how it occurs as well as MRI techniques to detect it.
authors: Geurts JJ, Barkhof F
source: Lancet Neurol. 2008 Sep;7(9):841-51.
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
|
|
MS News
 |
 |
| Summaries of MS news from websites around the world. |
|
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|